08/26/2025
Gives us hope!
🇦🇺✨ A historic moment for the FOP community in Australia! ✨🇦🇺
This weekend, the 2025 FOP Australia Conference opened with a milestone announcement from the Minister for Health, Hon Mark Butler MP:
👉 On September 1, 2025, palovarotene will become the first-ever treatment for FOP available through the PBS (Pharmaceutical Benefits Scheme).
The PBS helps make essential medicines more affordable by subsidizing their cost—ensuring access for those who need it most. For people living with FOP in Australia, this is the first time that treatment will be an option in the PBS. 💚
This milestone was made possible thanks to the leadership of the FOP Australia Board and the courage of individuals and families who shared their stories with government leaders and the Pharmaceutical Benefits Advisory Committee. Their voices highlighted the urgent need for treatment, significantly raised the profile of FOP with the government and healthcare professionals, and helped pave the way for future therapies.
👏 Thank you to the families for your advocacy and to FOP Australia for leading this monumental effort. You're building a future with greater access, awareness, and hope. 🌍💛